Navigation Links
Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option

SAN JOSE, Calif., March 18, 2013 /PRNewswire/ -- Ariosa Diagnostics, maker of the non-invasive Harmony™ Prenatal Test for risk assessment of common genetic conditions, has announced the expansion of the Harmony Prenatal Test to include the option of Y-chromosome analysis, which can provide information on fetal sex and aneuploidy as early as 10 weeks gestation.


The new "Harmony with Y test" will offer patients and their prenatal care providers with evaluation of the Y-chromosome through which fetal sex can be determined with greater than 99% accuracy. The test also assesses the risk of Y aneuploidy, such as XYY, which is due to an extra copy of chromosome Y. Y aneuploidy is estimated to be present in approximately 1 out of every 1,000 male newborns. 

The new Y test follows the recent announcement by Ariosa Diagnostics of expanding the Harmony test to allow for both self and non-self IVF pregnancies. Approximately 5% of all pregnancies, or 300,000, in the United States result from IVF, and the Harmony test allows access to non-invasive prenatal testing for this pregnancy population.

"Our new test offering for Y chromosome analysis provides an option to those women undergoing the Harmony test," said Ken Song , MD, CEO of Ariosa.  "XYY is more common than other autosomal trisomies, but has a varying clinical presentation and so proper counseling is needed prior to and following testing."

About Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.

Jen Bruursema
Ariosa Diagnostics

SOURCE Ariosa Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
2. PET/MR Scanner Holds Promise For Expanded Diagnostics
3. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
4. MGC Diagnostics Corporation Reports 2013 First Fiscal Quarter Operating Results
5. MD Buylines User Satisfaction Report Awards MGC Diagnostics Pulmonary Function Products Top Rating for Fourth Consecutive Quarter
6. MGC Diagnostics Corporation Announces Partnership with Frontera Strategies, LP
7. MGC Diagnostics Corporation to Report First Quarter Fiscal 2013 Financial Results on Tuesday, March 5, 2013
8. Quest Diagnostics to Sell HemoCue Business to Radiometer Medical ApS
9. Quest Diagnostics to Provide Nationwide Access to Nateras New Non-Invasive Prenatal Test
10. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
11. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
Post Your Comments:
(Date:10/13/2015)... VEGAS , Oct. 13, 2015 VIVA ... of vascular medicine and intervention through education and research, ... annual conference,  VIVA 2015 . Sixteen trial results, featuring ... released for the first time on Monday and Tuesday, ... --> --> Since ...
(Date:10/13/2015)... , Oct. 13, 2015  Kay Elledge, ... and Fellow American College of Obstetrics and Gynecology ... evolve by establishing the Genuine Self Medical Laser ... and men.  In recognition of Breast Cancer ... special promotion for MonaLisa Touch treatments ...
(Date:10/13/2015)... PITTSBURGH , Oct. 13, 2015  Mylan N.V. (Nasdaq: ... at 5:00 p.m. ET host a conference call and webcast ... Company plc (NYSE: PRGO ; TASE) shareholders through Mylan,s ... by Mylan,s Executive Chairman Robert J. Coury , CEO ... --> --> Mylan ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences ... $2 billion “Ever True” capital campaign. , The investment will result in cohesive ...
(Date:10/13/2015)... West Palm Beach, FL (PRWEB) , ... October 13, 2015 , ... ... acquisition of Global Laser Vision of San Diego, California. With brands including The LASIK ... 3.3 million successful procedures, making it the nationwide leader in laser vision correction. , ...
(Date:10/13/2015)... N.J. (PRWEB) , ... October 13, 2015 , ... ... media enterprise focused on cancer patients, today announced a new partnership with the ... patients battling this rare type of non-Hodgkin’s lymphoma, their families and physicians. ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... beverage companies in the United States, today announced the release of its limited ... and new Cranberry Cocktail Agua Fresca. All feature the unique flavor combinations and ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a ... delivers innovative health programs and interventions via mobile devices that provide a framework ...
Breaking Medicine News(10 mins):